Iopamidol 150. A low iodine content non-ionic water-soluble contrast medium for CT myelocisternography.

A. Beltramello, M. Leonardi, E. Biasizzo, G. Piscitelli

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Results of a clinical trial in CT myelocisternography performed with a new reduced concentration of iopamidol (150 mg I/ml) are reported. This compound is characterized by very low osmolality and osmotic pressure close to those of blood and CSF. Thirty patients were examined. Before, during and after the procedure pulse rate and blood pressure were recorded, EEG was taken and neurologic examination performed. After the examination no alteration in these parameters was recorded. The demonstration of the subarachnoid space and related structures was invariably adequate for diagnosis. In no case was a repeat study using a higher concentration of contrast medium needed. Mild reactions occurred only in three patients (10%). The authors conclude that iopamidol 150, owing to its safety and good imaging capacity, is useful in CT imaging of the subarachnoid space.

Original languageEnglish
Pages (from-to)542-544
Number of pages3
JournalActa Radiologica, Supplement
Volume369
Publication statusPublished - 1986

Fingerprint

Iopamidol
Subarachnoid Space
Iodine
Contrast Media
Blood Pressure
Water
Osmotic Pressure
Neurologic Examination
Osmolar Concentration
Electroencephalography
Heart Rate
Clinical Trials
Safety

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Radiological and Ultrasound Technology

Cite this

Iopamidol 150. A low iodine content non-ionic water-soluble contrast medium for CT myelocisternography. / Beltramello, A.; Leonardi, M.; Biasizzo, E.; Piscitelli, G.

In: Acta Radiologica, Supplement, Vol. 369, 1986, p. 542-544.

Research output: Contribution to journalArticle

Beltramello, A, Leonardi, M, Biasizzo, E & Piscitelli, G 1986, 'Iopamidol 150. A low iodine content non-ionic water-soluble contrast medium for CT myelocisternography.', Acta Radiologica, Supplement, vol. 369, pp. 542-544.
Beltramello, A. ; Leonardi, M. ; Biasizzo, E. ; Piscitelli, G. / Iopamidol 150. A low iodine content non-ionic water-soluble contrast medium for CT myelocisternography. In: Acta Radiologica, Supplement. 1986 ; Vol. 369. pp. 542-544.
@article{ce680d87de1642559b3f9ac6cfdc8860,
title = "Iopamidol 150. A low iodine content non-ionic water-soluble contrast medium for CT myelocisternography.",
abstract = "Results of a clinical trial in CT myelocisternography performed with a new reduced concentration of iopamidol (150 mg I/ml) are reported. This compound is characterized by very low osmolality and osmotic pressure close to those of blood and CSF. Thirty patients were examined. Before, during and after the procedure pulse rate and blood pressure were recorded, EEG was taken and neurologic examination performed. After the examination no alteration in these parameters was recorded. The demonstration of the subarachnoid space and related structures was invariably adequate for diagnosis. In no case was a repeat study using a higher concentration of contrast medium needed. Mild reactions occurred only in three patients (10{\%}). The authors conclude that iopamidol 150, owing to its safety and good imaging capacity, is useful in CT imaging of the subarachnoid space.",
author = "A. Beltramello and M. Leonardi and E. Biasizzo and G. Piscitelli",
year = "1986",
language = "English",
volume = "369",
pages = "542--544",
journal = "Acta Radiologica, Supplement",
issn = "0365-5954",
publisher = "Blackwell Publishing",

}

TY - JOUR

T1 - Iopamidol 150. A low iodine content non-ionic water-soluble contrast medium for CT myelocisternography.

AU - Beltramello, A.

AU - Leonardi, M.

AU - Biasizzo, E.

AU - Piscitelli, G.

PY - 1986

Y1 - 1986

N2 - Results of a clinical trial in CT myelocisternography performed with a new reduced concentration of iopamidol (150 mg I/ml) are reported. This compound is characterized by very low osmolality and osmotic pressure close to those of blood and CSF. Thirty patients were examined. Before, during and after the procedure pulse rate and blood pressure were recorded, EEG was taken and neurologic examination performed. After the examination no alteration in these parameters was recorded. The demonstration of the subarachnoid space and related structures was invariably adequate for diagnosis. In no case was a repeat study using a higher concentration of contrast medium needed. Mild reactions occurred only in three patients (10%). The authors conclude that iopamidol 150, owing to its safety and good imaging capacity, is useful in CT imaging of the subarachnoid space.

AB - Results of a clinical trial in CT myelocisternography performed with a new reduced concentration of iopamidol (150 mg I/ml) are reported. This compound is characterized by very low osmolality and osmotic pressure close to those of blood and CSF. Thirty patients were examined. Before, during and after the procedure pulse rate and blood pressure were recorded, EEG was taken and neurologic examination performed. After the examination no alteration in these parameters was recorded. The demonstration of the subarachnoid space and related structures was invariably adequate for diagnosis. In no case was a repeat study using a higher concentration of contrast medium needed. Mild reactions occurred only in three patients (10%). The authors conclude that iopamidol 150, owing to its safety and good imaging capacity, is useful in CT imaging of the subarachnoid space.

UR - http://www.scopus.com/inward/record.url?scp=0022821268&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022821268&partnerID=8YFLogxK

M3 - Article

C2 - 2980553

AN - SCOPUS:0022821268

VL - 369

SP - 542

EP - 544

JO - Acta Radiologica, Supplement

JF - Acta Radiologica, Supplement

SN - 0365-5954

ER -